TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Get Free Report) shares were up 2.3% on Friday . The stock traded as high as $1.20 and last traded at $0.90. 9,780 shares were traded during trading, an increase of 87% from the average session volume of 5,236 shares. The stock had previously closed at $0.8798.
TriSalus Life Sciences Stock Up 2.3%
The stock has a 50 day simple moving average of $0.73 and a 200 day simple moving average of $1.10.
Institutional Trading of TriSalus Life Sciences
Several hedge funds have recently made changes to their positions in the stock. Citadel Advisors LLC boosted its position in TriSalus Life Sciences by 439.0% during the 3rd quarter. Citadel Advisors LLC now owns 126,876 shares of the company’s stock valued at $199,000 after purchasing an additional 103,336 shares during the period. Cerity Partners LLC bought a new position in TriSalus Life Sciences during the 4th quarter worth $1,374,000. Fort Baker Capital Management LP acquired a new stake in TriSalus Life Sciences in the fourth quarter worth $44,000. Finally, Aristeia Capital L.L.C. acquired a new stake in TriSalus Life Sciences in the fourth quarter worth $43,000.
TriSalus Life Sciences Company Profile
TriSalus Life Sciences, Inc is a clinical-stage medical device company focused on developing minimally invasive technologies to enhance the precision and efficacy of cancer radiation therapy. The company’s lead product, the TriMark™ Tissue Marker System, is designed to provide high-visibility soft-tissue fiducial markers that assist oncologists in accurately targeting tumors during radiotherapy. By deploying bio-absorbable markers directly into tumor beds, TriSalus aims to improve treatment planning, patient comfort and long-term follow-up imaging.
Founded in 2015 and headquartered in Plymouth, Minnesota, TriSalus Life Sciences pursues a platform approach to oncology treatment, with research and development efforts centered on novel delivery devices and advanced imaging solutions.
Read More
- Five stocks we like better than TriSalus Life Sciences
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
- MarketBeat Week in Review – 07/06 – 07/10
- AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
Receive News & Ratings for TriSalus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriSalus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
